Skip to main content
. Author manuscript; available in PMC: 2018 Mar 7.
Published in final edited form as: Circulation. 2017 Feb 6;135(10):e604–e633. doi: 10.1161/CIR.0000000000000477

Figure 3. Periprocedural management of patients on NOACs (non–vitamin K antagonist oral anticoagulants).

Figure 3

CrCl indicates creatinine clearance; ICD, implantable cardioverter-defibrillator; PT, prothrombin time; SVT, supraventricular tachycardia; TE, thromboembolic event; TIA, transient ischemic attack; and VTE, venous thromboembolism.

*Bridging may be considered in patients with a history of systemic embolus in the last 6 weeks.110a